Pulse Biosciences was founded in 2014 and is headquartered in Burlingame, US
Pulse Biosciences Office Locations
Pulse Biosciences has an office in Burlingame
Burlingame, US (HQ)
104 849 Mitten Rd
Pulse Biosciences Data and Metrics
Pulse Biosciences Financial Metrics
USD
Net income (Q1, 2017) | (3.2 m) |
Market capitalization (17-Aug-2017) | 304.2 m |
Cash (31-Mar-2017) | 2.8 m |
Pulse Biosciences's current market capitalization is $304.2 m.
| USD | FY, 2016 |
|---|---|
R&D expense | 1.8 b |
General and administrative expense | 870 m |
Operating expense total | 2.8 b |
Interest income | 34 m |
Net Income | (2.8 b) |
| USD | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|
R&D expense | 990 k | 1.5 m | 1.7 m | 1.9 m |
General and administrative expense | 528 k | 642 k | 893 k | 1.2 m |
Operating expense total | 1.5 m | 2.1 m | 2.6 m | 3.1 m |
Interest income | 3 k | 31 k | 39 k | |
Net Income | (1.7 m) | (2.3 m) | (2.8 m) | (3.2 m) |
| USD | FY, 2016 |
|---|---|
Cash | 2.1 m |
Inventories | 268 k |
Current Assets | 16.7 m |
Goodwill | 2.8 m |
Total Assets | 26.3 m |
Accounts Payable | 265 k |
Current Liabilities | 1 m |
Additional Paid-in Capital | 37.9 m |
Retained Earnings | (12.6 m) |
Total Equity | 25.3 m |
Financial Leverage | 1 x |
| USD | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|
Cash | 2.1 m | 20.2 m | 4.6 m | 2.8 m |
Current Assets | 2.6 m | 21 m | 19 m | 19.1 m |
Goodwill | 2.8 m | 2.8 m | 2.8 m | 2.8 m |
Total Assets | 12.8 m | 31.1 m | 28.8 m | 28.6 m |
Accounts Payable | 296 k | 333 k | 446 k | 782 k |
Current Liabilities | 650 k | 590 k | 967 k | 1.2 m |
Additional Paid-in Capital | 16.9 m | 37.5 m | 37.7 m | 43.1 m |
Retained Earnings | (4.8 m) | (7 m) | (9.8 m) | (15.8 m) |
Total Equity | 12.2 m | 30.5 m | 27.9 m | 27.3 m |
Financial Leverage | 1.1 x | 1 x | 1 x | 1 x |
| USD | FY, 2016 |
|---|---|
Net Income | (2.8 b) |
Depreciation and Amortization | 167 m |
Inventories | 12 k |
Accounts Payable | 29 k |
Cash From Operating Activities | (101 k) |
Purchases of PP&E | (46 k) |
Cash From Investing Activities | (45 k) |
Cash From Financing Activities | 7.2 m |
| USD | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|
Net Income | (1.7 m) | (2.3 m) | (2.8 m) | (3.2 m) |
Depreciation and Amortization | 166 k | 166 k | 166 k | 166 k |
Accounts Payable | 296 k | 333 k | 446 k | 782 k |
| Y, 2017 | |
|---|---|
Financial Leverage | 1 x |
Pulse Biosciences Operating Metrics
Pulse Biosciences's Patent Applications was reported to be 61 in FY, 2016
- Source: SEC Filings
